Flexible, durable DuPont™ Hytrel® key to new Niagara Foot™ prosthetic foot design

Photo: DuPont <br>A key aspect of the Niagara Foot™ prosthetic foot lies in its keel – a single, S-shaped part, injection-moulded from DuPont™ Hytrel® thermoplastic polyester elastomer, which acts like a spring to provide energy storage and return during the gait cycle.

Its novel, energy-return design relies on the stiff yet, flexible properties of DuPont™ Hytrel® thermoplastic polyester elastomer to provide user benefits in terms of stability, effectiveness and comfort.

It was developed as part of the landmine victims’ relief program of the Canadian Centre for Mine Action Technology by Niagara Prosthetic & Orthotics International Ltd. (Ontario, Canada) with support from industry partners Hippo Design (Montebello, Québec), Précicad (Québec City, Québec), DuPont (USA & Canada) and a team of engineers from Queen’s University (Kingston, Ontario). It is available for purchase as of October 2007.

The Niagara Foot™ was designed specifically for individuals with active lifestyles and those who walk on rugged ground. A key aspect of its design lies in its keel – a single, S-shaped part, injection-moulded from Hytrel® 8238, which acts like a spring to provide energy storage and return during the gait cycle. “The energy-return principle incorporated into the design of the Niagara Foot™ allows the user to walk more naturally than conventional designs,” explains Rob Gabourie, founder of Niagara Prosthetic & Orthotics Corporation and inventor of the Niagara Foot™. “Patients are able to detect and appreciate the performance of this device, which decreases the muscular effort required for walking.”

The combination of low flex fatigue and high stress resistance provided by Hytrel® was key to achieving this concept – indeed Rob Gabourie is convinced that his design will not work with any other material. Whereas a number of other materials, including poloxymethylenes (POM) and polyamides, were unable to pass two million cyclic loads due to deformation or, in some cases, structural failure, Hytrel® clearly exceeded this milestone during rigorous testing carried out at Queen’s University, as required by ISO 10328 standards. “Of particular interest is the ability of Hytrel® to store and release energy,” states Dan Curran-Blaney, application development representative at DuPont Canada. “It complies with this specific design by mimicking the natural movement of the ankle complex. Yet, beyond this fundamental requirement, the material must be able to endure severe cycling of these loads, as experienced in normal usage. The unique attribute of Hytrel® is its ability to recover its shape, while continuously cycling under load, which enhances its spring like properties.”

Further clarification for its exceptional performance in such a demanding application is provided by the material’s processing behaviour, as Helga Plishka, technical representative at DuPont Canada, explains: “The geometry of the current design requires abnormally thick wall sections. Because Hytrel® flows easily to produce a well-packed part, the occurrence of the voids, which were prevalent in parts moulded with POM or polyamide, was eliminated – essential for achieving flex fatigue resistance.” Beyond the performance of Hytrel®, Rob Gabourie cites the DuPont’s technical support and knowledge, as well as its consistent quality of supply, as the reasons behind his choice of material supplier.

In order to predict the behaviour and service life of the Niagara Foot™, it has been tested in a series of laboratory, clinical and field trials, including performance tests with amputees in Canada and San Salvador. It is available in a variety of sizes with an optional cosmetic cover. Designed for use by active adults up to 80 kilograms in weight, local prosthetists can easily customise the response of the Niagara Foot™ to the user’s weight, activity levels and personal preferences. It is available via the website www.niagrafoot.com.

Niagara Prosthetic & Orthotics (NPO) has been serving the mobility and recovery needs of patients across Canada's Niagara region and beyond for over 25 years. Its founder, Robert Gabourie, has worked with engineers from Queen's University and materials specialists from Dupont to develop two new products, the Niagara Foot and the Niagara Knee Joint™. Niagara Prosthetic & Orthotics International Ltd. (NPOI) was created to market and distribute these products around the country and around the world. NPO has partnered with the charitable organization – Niagara Orthopaedics Worldwide – to distribute its products, in particular the Niagara Foot, to areas where the need is greatest.

The DuPont Engineering Polymers business manufactures and sells Crastin® PBT and Rynite® PET thermoplastic polyester resins, Delrin® acetal resins, Hytrel® thermoplastic polyester elastomers, DuPont™ ETPV engineering thermoplastic vulcanizates, Minlon® mineral reinforced nylon resins, Thermx® PCT polycyclohexylene dimethyl terephthalate, Tynex® filaments, Vespel® parts and shapes, Zenite® LCP liquid crystal polymers, Zytel® nylon resins and Zytel® HTN high-performance polyamides. These products serve global markets in the aerospace, appliance, automotive, consumer, electrical, electronic, industrial, sporting goods and many other diversified industries.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont™, The miracles of science™ and all product names denoted with ® are registered trademarks or trademarks of DuPont or its affiliates.

This press release was prepared with input provided by:
Niagara Prosthetics & Orthotics International Ltd.
547 Glenridge Avenue,
St. Catherines,
Ontario,
Canada L2T 4C2
Contact: Robert Gabourie CPO
Tel.: +1 905-688-2553
E-Mail: Rgabourie1@cogeco.ca

Media Contact

Horst Ulrich Reimer Du Pont

More Information:

http://www.dupont.com

All latest news from the category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to home

Comments (0)

Write a comment

Newest articles

Skyrmions move at record speeds

… a step towards the computing of the future. An international research team led by scientists from the CNRS1 has discovered that the magnetic nanobubbles2 known as skyrmions can be…

A flexible and efficient DC power converter for sustainable-energy microgrids

A new DC-DC power converter is superior to previous designs and paves the way for more efficient, reliable and sustainable energy storage and conversion solutions. The Kobe University development can…

Technical Trials for Easing the (Cosmological) Tension

A new study sorts through models attempting to solve one of the major challenges of contemporary cosmic science, the measurement of its expansion. Thanks to the dizzying growth of cosmic…

Partners & Sponsors